Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Damning FDA-483: Philips Didn’t Investigate 222,000 Complaints Of Possible Degraded Foam In Breathing Devices
FDA investigator makes 8 observations during recent inspection of Philips Respironics facility
Nov 15 2021
•
By
Shawn M. Schmitt
It's dark days for Philips • Source: Alamy
More from Compliance
More from Policy & Regulation